Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$261M |
| 2 |
Alibaba
BABA
|
+$233M |
| 3 |
Truist Financial
TFC
|
+$191M |
| 4 |
Microsoft
MSFT
|
+$160M |
| 5 |
Amazon
AMZN
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$415M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$186M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$73.8M |
| 4 |
Oracle
ORCL
|
+$25.8M |
| 5 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 15.12% |
| 3 | Healthcare | 12.68% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Sempra
SRE
$58.6B
| $447M | 0.21% |
5,905,162
+298,482
| +5% | +$21.9M |
|
102
S&P Global
SPGI
$122B
| $447M | 0.21% |
1,637,680
+28,317
| +2% | +$7.36M |
|
103
TC Energy
TRP
$70.9B
| $441M | 0.21% |
8,278,017
+498,079
| +6% | +$25.5M |
|
104
Becton Dickinson
BDX
$45.6B
| $438M | 0.21% |
1,651,576
+33,643
| +2% | +$8.39M |
|
|
FISV
105
Fiserv Inc
FISV
$28.8B
| $431M | 0.21% |
3,729,171
+36,894
| +1% | +$4.07M |
|
106
CME Group
CME
$96.1B
| $428M | 0.2% |
2,131,078
+29,666
| +1% | +$6.09M |
|
107
Intuitive Surgical
ISRG
$126B
| $428M | 0.2% |
2,171,607
+51,453
| +2% | +$9.63M |
|
108
Phillips 66
PSX
$84.4B
| $417M | 0.2% |
3,741,767
-22,258
| -0.6% | -$2.5M |
|
109
CSX Corp
CSX
$93B
| $415M | 0.2% |
17,222,955
+338,061
| +2% | +$8M |
|
|
MRSH
110
Marsh
MRSH
$91.4B
| $414M | 0.2% |
3,713,986
+28,169
| +0.8% | +$2.94M |
|
111
Colgate-Palmolive
CL
$73.3B
| $411M | 0.2% |
5,967,311
+71,547
| +1% | +$4.88M |
|
112
Zoetis
ZTS
$31.9B
| $406M | 0.19% |
3,069,196
+94,182
| +3% | +$11.7M |
|
113
Consolidated Edison
ED
$40.4B
| $405M | 0.19% |
4,471,854
+243,659
| +6% | +$21.8M |
|
114
Illinois Tool Works
ITW
$81.6B
| $403M | 0.19% |
2,245,137
+41,011
| +2% | +$6.95M |
|
115
Canadian National Railway
CNI
$76.9B
| $403M | 0.19% |
4,444,139
+90,602
| +2% | +$8.14M |
|
116
Micron Technology
MU
$988B
| $401M | 0.19% |
7,452,424
+290,835
| +4% | +$13.9M |
|
|
AGN
117
DELISTED
Allergan plc
AGN
| $400M | 0.19% |
2,094,474
+46,332
| +2% | +$8.36M |
|
118
Boston Scientific
BSX
$68.4B
| $397M | 0.19% |
8,781,429
+226,587
| +3% | +$9.48M |
|
|
RTN
119
DELISTED
Raytheon Company
RTN
| $396M | 0.19% |
1,800,428
-68,303
| -4% | -$14.4M |
|
120
Norfolk Southern
NSC
$75B
| $391M | 0.19% |
2,013,766
+49,937
| +3% | +$9.37M |
|
121
Morgan Stanley
MS
$330B
| $382M | 0.18% |
7,473,587
+33,577
| +0.5% | +$1.59M |
|
122
SLB Ltd
SLB
$72.6B
| $380M | 0.18% |
9,454,535
+446,039
| +5% | +$15.9M |
|
123
Xcel Energy
XEL
$48.8B
| $379M | 0.18% |
5,974,687
+271,872
| +5% | +$17M |
|
124
Biogen
BIIB
$30.7B
| $373M | 0.18% |
1,255,408
+15,724
| +1% | +$4.36M |
|
125
Kinder Morgan
KMI
$70.5B
| $372M | 0.18% |
17,551,132
+627,077
| +4% | +$12.7M |
|
Similar funds
Legal & General Group's Q4 2019 Portfolio in Review
As of Q4 2019, Legal & General Group held 3,425 positions worth $210B, up 11% from $190B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.9%. Legal & General Group opened 77 new positions and exited 57, leaving the 3,425-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 425,000 shares worth $19.1M.
- Legal & General Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $261M increase.
- Legal & General Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $25.8M.
- Legal & General Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
- Legal & General Group's ten largest holdings make up 18% of its $210B portfolio in Q4 2019.
- Legal & General Group opened 77 new positions and closed 57 in Q4 2019.
- Legal & General Group's portfolio value rose 11% quarter-over-quarter to $210B.
Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.